Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

MPS1 kinase inhibitor NMS-01940153E

A selective inhibitor of the serine/threonine-protein kinase monopolar spindle 1 (Mps1; TTK), with potential antineoplastic activity. Upon administration, MPS1 kinase inhibitor NMS-01940153E targets, binds to and inhibits the activity of Mps1, a core component of the spindle assembly checkpoint (SAC). Inhibition of Mps1 activity compromises the functioning of SAC, increases chromosome missegregation errors and decreases cancer cell viability. This inhibits tumor cell proliferation. Mps1, a dual-specificity protein kinase expressed in proliferating normal tissues and aberrantly overexpressed in certain tumor types, is activated during mitosis and is essential in proper SAC function, chromosomal alignment and segregation during cellular division.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:monopolar spindle 1 inhibitor NMS-01940153E
MPS1 inhibitor NMS-01940153E
Code name:NMS 01940153E
NMS 153
NMS-01940153E
NMS-153
NMS01940153E
NMS153
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search